Over the past few years, there has been evidence of the increasing prevalence of autoimmune diseases. Autoimmune diseases consist of many complex disorders of unknown etiology resulting in immune responses to self-antigens. The immune system, and its function, is under complex and integrated control and its disruption can be triggered by multiple factors. Autoimmunity development is influenced by multiple factors and is thought to be a result of interactions between genetic and environmental factors. Here, we review the role of a specific environmental factor, bisphenol A (BPA), in the pathogenesis of autoimmune diseases. BPA belongs to the group of environmental estrogens that have been identified as risk factors involved in the development of autoimmune diseases.
CutoloMStraubRH. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther2009; 11: 218–218.
2.
NussinovitchUShoenfeldY. The role of gender and organ specific autoimmunity. Autoimmun Rev2012; 11: A377–A385.
3.
RogersJAMetzLYongVW. Review: Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms. Mol Immunol2013; 53: 421–430.
RochesterJR. Bisphenol A and human health: A review of the literature. Reprod Toxicol2013; 42: 132–155.
6.
WalshSJRauLM. Autoimmune diseases: A leading cause of death among young and middle-aged women in the United States. Am J Public Health2000; 90: 1463–1466.
7.
StraubRH. The complex role of estrogens in inflammation. Endocr Rev2007; 28: 521–574.
8.
StraubRHBijlsmaJWMasiACutoloM. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases – the 10-year update. Semin Arthritis Rheum2013; 43: 392–404.
9.
HallJMCouseJFKorachKS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem2001; 276: 36869–36872.
10.
NilssonSMakelaSTreuterE. Mechanisms of estrogen action. Physiol Rev2001; 81: 1535–1565.
11.
Cohen-SolalJFJeganathanVHillL. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus2008; 17: 528–532.
12.
CutoloMCapellinoSSulliA. Estrogens and autoimmune diseases. Ann N Y Acad Sci2006; 1089: 538–547.
13.
LangTJ. Estrogen as an immunomodulator. Clin Immunol2004; 113: 224–230.
14.
NalbandianGKovatsS. Understanding sex biases in immunity: Effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res2005; 31: 91–106.
15.
PetriM. Sex hormones and systemic lupus erythematosus. Lupus2008; 17: 412–415.
16.
GustafssonJA. Estrogen receptor beta – a new dimension in estrogen mechanism of action. J Endocrinol1999; 163: 379–383.
17.
Alonso-MagdalenaPRoperoABSorianoS. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cell Endocrinol2012; 355: 201–207.
18.
PrattWBToftDO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev1997; 18: 306–360.
KushnerPJAgardDFengWJ. Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp2000; 230: 20–26. discussion 27–40.
21.
SavilleBWormkeMWangF. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem2000; 275: 5379–5387.
22.
SafeSKimK. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol2004; 77: 1–36.
23.
CutoloMAccardoSVillaggioB. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab1996; 81: 820–827.
24.
CutoloMSulliAStraubRH. Estrogen metabolism and autoimmunity. Autoimmun Rev2012; 11: A460–A464.
25.
ChighizolaCMeroniPL. The role of environmental estrogens and autoimmunity. Autoimmun Rev2012; 11: A493–A501.
26.
KarpuzogluEZoualiM. The multi-faceted influences of estrogen on lymphocytes: Toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol2011; 40: 16–26.
27.
VerthelyiDAhmedSA. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology1994; 135: 2615–2622.
28.
VerthelyiDIAhmedSA. Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell Immunol1998; 189: 125–134.
29.
MedinaKLStrasserAKincadePW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood2000; 95: 2059–2067.
30.
CutoloMCapellinoSStraubRH. Oestrogens in rheumatic diseases: Friend or foe?Rheumatology (Oxford)2008; 47(Suppl 3): iii2–iii5.
31.
OstensenMBrucatoACarpH. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford)2011; 50: 657–664.
32.
OstensenMVilligerPMForgerF. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev2012; 11: A437–446.
33.
SchmidtMHartungRCapellinoSCutoloMPfeifer-LeegAStraubRH. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum2009; 60: 2913–2922.
34.
GonzalezDADiazBBRodriguez Perez MdelCHernandezAGChicoBNde LeonAC. Sex hormones and autoimmunity. Immunol Lett2010; 133: 6–13.
35.
WhitelawDAJessopSJ. Major flares in women with SLE on combined oral contraception. Clin2007; 26: 2163–2165.
36.
WatsonCSBulayevaNNWozniakALAlyeaRA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids2007; 72: 124–134.
37.
AhmedSA. The immune system as a potential target for environmental estrogens (endocrine disrupters): A new emerging field. Toxicology2000; 150: 191–206.
38.
DarbrePD. Metalloestrogens: An emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol2006; 26: 191–197.
39.
NollerKLBlairPBO'BrienPC. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril1988; 49: 1080–1082.
40.
WingardDLTurielJ. Long-term effects of exposure to diethylstilbestrol. The West J Med1988; 149: 551–554.
41.
GrayLEJrOstbyJWilsonV. Xenoendocrine disrupters-tiered screening and testing: Filling key data gaps. Toxicology2002; 181–182: 371–382.
42.
Greiner E, Kaelin T, Nakamura K. Bisphenol A. CEH Report by SRI consulting, 2007.
43.
StaplesCADornPBKleckaGMO'BlockSTHarrisLR. A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere1998; 36: 2149–2173.
44.
RichterCABirnbaumLSFarabolliniF. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol2007; 24: 199–224.
45.
VandenbergLNHauserRMarcusMOleaNWelshonsWV. Human exposure to bisphenol A (BPA). Reprod Toxicol2007; 24: 139–177.
46.
WelshonsWVNagelSCvom SaalFS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology2006; 147: S56–S69.
47.
WitorschRJ. Endocrine disruptors: Can biological effects and environmental risks be predicted?Regul Toxicol Pharmacol2002; 36: 118–130.
48.
Alonso-MagdalenaPRoperoABCarreraMP. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PloS One2008; 3: e2069–e2069.
49.
AraseSIshiiKIgarashiK. Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus. Biol Reprod2011; 84: 734–742.
50.
StahlhutRWWelshonsWVSwanSH. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect2009; 117: 784–789.
51.
ZsarnovszkyALeHHWangHSBelcherSM. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: Potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology2005; 146: 5388–5396.
52.
RoyPSalminenHKoskimiesP. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J Steroid Biochem Mol Biol2004; 88: 157–166.
53.
UrbatzkaRBotteroSMandichALutzIKloasW. Endocrine disrupters with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: I. Effects on sex steroid levels and biomarker expression. Comp Biochem Physiol C Toxicol Pharmacol2007; 144: 310–318.
54.
GouldJCLeonardLSManessSC. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol1998; 142: 203–214.
55.
KrishnanAVStathisPPermuthSFTokesLFeldmanD. Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology1993; 132: 2279–2286.
56.
SteinmetzRBrownNGAllenDLBigsbyRMBen-JonathanN. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology1997; 138: 1780–1786.
57.
KundakovicMGudsnukKFranksB. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A2013; 110: 9956–9961.
58.
VandenbergLNMaffiniMVSonnenscheinCRubinBSSotoAM. Bisphenol-A and the great divide: A review of controversies in the field of endocrine disruption. Endocr Rev2009; 30: 75–95.
59.
XuHYangMQiuWPanCWuM. The impact of endocrine-disrupting chemicals on oxidative stress and innate immune response in zebrafish embryos. Environ Toxicol Chem2013; 32: 1793–1799.
60.
InaderaHSekiyaTYoshimuraTMatsushimaK. Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology2000; 141: 50–59.
61.
LeeMHChungSWKangBY. Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: Involvement of nuclear factor-AT and Ca2+. Immunology2003; 109: 76–86.
62.
SeguraJJJimenez-RubioAPulgarROleaNGuerreroJMCalvoJR. In vitro effect of the resin component bisphenol A on substrate adherence capacity of macrophages. J Endod1999; 25: 341–344.
63.
TianXTakamotoMSuganeK. Bisphenol A promotes IL-4 production by Th2 cells. Int Arch Allergy Immunol2003; 132: 240–247.
64.
YoshinoSYamakiKYanagisawaRTakanoHHayashiHMoriY. Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and TH1 and TH2 immune responses in mice. Br J Pharmacol2003; 138: 1271–1276.
65.
LeeJLimKT. Plant-originated glycoprotein (36 kDa) suppresses interleukin-4 and -10 in bisphenol A-stimulated primary cultured mouse lymphocytes. Drug Chem Toxicol2010; 33: 421–429.
66.
GuoHLiuTUemuraY. Bisphenol A in combination with TNF-alpha selectively induces Th2 cell-promoting dendritic cells in vitro with an estrogen-like activity. Cell Mol Immunol2010; 7: 227–234.
67.
LiuYShiJLuJ. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate immun2009; 15: 169–178.
68.
YurinoHIshikawaSSatoT. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol Sci2004; 81: 139–147.
69.
GotoMTakano-IshikawaYOnoHYoshidaMYamakiKShinmotoH. Orally administered bisphenol A disturbed antigen specific immunoresponses in the naive condition. Biosci Biotechnol Biochem2007; 71: 2136–2143.
70.
KuanYHLiYCHuangFMChangYC. The upregulation of tumour necrosis factor-alpha and surface antigens expression on macrophages by bisphenol A-glycidyl-methacrylate. Int Endod J2012; 45: 619–626.
71.
ShellySBoazMOrbachH. Prolactin and autoimmunity. Autoimmun Rev2012; 11: A465–A470.
72.
KharrazianD. The potential roles of Bisphenol A (BPA) pathogenesis in autoimmunity. Autoimmune Dis2014; 2014: 743616–743616.
73.
Midoro-HoriutiTTiwariRWatsonCSGoldblumRM. Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups. Environ Health Perspect2010; 118: 273–277.
74.
NakajimaYGoldblumRMMidoro-HoriutiT. Fetal exposure to bisphenol A as a risk factor for the development of childhood asthma: an animal model study. Environ Health2012; 11: 8–8.
75.
DonohueKMMillerRLPerzanowskiMS. Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children. J Allergy Clin Immunol2013; 131: 736–742.
76.
O'BrienEBerginILDolinoyDC. Perinatal bisphenol A exposure beginning before gestation enhances allergen sensitization, but not pulmonary inflammation, in adult mice. J Dev Orig Health Dis2014; 5: 121–131.
77.
VaidyaSVKulkarniH. Association of urinary bisphenol A concentration with allergic asthma: Results from the National Health and Nutrition Examination Survey 2005–2006. J Asthma2012; 49: 800–806.
78.
LangIAGallowayTSScarlettA. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA2008; 300: 1303–1310.
79.
Montano-LozaAJCrispin-AcunaJCRemes-TrocheJMUribeM. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren's syndrome. Ann Hepatol2007; 6: 150–155.
80.
AngleBMDoRPPonziD. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): Evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol2013; 42: 256–268.
81.
ShankarATeppalaS. Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab2011; 96: 3822–3826.
82.
BodinJBollingAKBecherRKuperFLovikMNygaardUC. Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. Toxicol Sci2014; 137: 311–323.
83.
OrtonSMHerreraBMYeeIM. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol2006; 5: 932–936.
84.
Weinstock-GuttmanBJacobsLDBrownscheidleCM. Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler2003; 9: 293–298.
85.
ItohKYaoiTFushikiS. Bisphenol A, an endocrine-disrupting chemical, and brain development. Neuropathology2012; 32: 447–457.
86.
NakamuraKItohKSugimotoTFushikiS. Prenatal exposure to bisphenol A affects adult murine neocortical structure. Neurosci Lett2007; 420: 100–105.
87.
KomadaMItohSKawachiKKagawaNIkedaYNagaoT. Newborn mice exposed prenatally to bisphenol A show hyperactivity and defective neocortical development. Toxicology2014; 323C: 51–60.
88.
KrementsovDNKatchyACaseLK. Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol a exposure as an environmental factor in increasing multiple sclerosis risk. Toxicol Sci2013; 135: 91–102.
89.
Brinkmeyer-LangfordCRodriguesAKochanKJ. Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis. Autoimmunity2014; 47: 57–66.
